{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_codes_comments in Code Comments (approximate match)
Status:
US Approved Rx
(2022)
Source:
BLA761238
(2022)
Source URL:
First approved in 2022
Source:
BLA761238
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2021)
Source:
BLA761196
(2021)
Source URL:
First approved in 2021
Source:
BLA761196
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2020)
Source:
BLA761163
(2020)
Source URL:
First approved in 2020
Source:
BLA761163
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2019)
Source:
BLA761121
(2019)
Source URL:
First approved in 2019
Source:
BLA761121
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
First approved in 2017
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761040
(2017)
Source URL:
First approved in 2017
Source:
BLA761040
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2016)
Source:
BLA125509
(2016)
Source URL:
First approved in 2016
Source:
BLA125509
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2016)
First approved in 2016
Class:
PROTEIN
Status:
US Approved Rx
(2015)
Source:
BLA125511
(2015)
Source URL:
First approved in 2015
Source:
BLA125511
Source URL:
Class:
PROTEIN
Parathyroid hormone (PTH) is an 84-amino acid peptide that regulates the function of osteoblasts and osteocytes and is secreted by the parathyroid gland in response to changes in the concentration of extracellular calcium. Parathyroid hormone is approved under the brand name NATPARA as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism. It is also available for treatment of postmenopausal osteoporosis in many European countries. Parathyroid hormone is an activator of parathyroid hormone 2 receptor. In addition, was shown, that downregulation of Notch in osteoblasts and osteocytes may represent a mechanism contributing to the anabolic effects of parathyroid hormone in bone.
Status:
US Approved Rx
(2020)
Source:
BLA761145
(2020)
Source URL:
First approved in 2015
Source:
BLA761036
Source URL:
Class:
PROTEIN
